Abstract: Disclosed is a liquid medicament/supplement composition including a non-winterized marine source oil (e.g., oil derived from fish, krill, and/or squid), a food grade or pharmaceutically acceptable form of vitamin D3 or a derivative thereof admixed in the non-winterized marine source oil, a food grade or pharmaceutically acceptable form of vitamin A or a derivative thereof admixed in the non-winterized marine source oil, optionally a food grade or pharmaceutically acceptable form of CoQ10 or a derivative thereof admixed in the non-winterized marine source oil, a food grade or pharmaceutically acceptable form of concentrated eicosapentaenoic acid and docosahexaenoic acid or ethyl ester, glyceride ester or salt of the acid and polyphenol rich vegetable oil admixed in the non-winterized marine source oil, and optionally a food grade or pharmaceutically acceptable form of melatonin or a derivative thereof admixed in the non-winterized marine source oil.
Type:
Grant
Filed:
June 16, 2020
Date of Patent:
March 2, 2021
Assignee:
AMBO INNOVATIONS, LLC
Inventors:
Bo Reidar Martinsen, Leif Andreas Riege
Abstract: Embodiments of the present invention are directed to methods, apparatus and articles of manufacture that feature omega-3 fatty acids co-processed with flavonoid and lipophilic antioxidants for improved stability.
Abstract: Disclosed is a liquid medicament/supplement composition including a non-winterized marine source oil (e.g., oil derived from fish, krill, and/or squid), a food grade or pharmaceutically acceptable form of vitamin D3 or a derivative thereof admixed in the non-winterized marine source oil, a food grade or pharmaceutically acceptable form of vitamin A or a derivative thereof admixed in the non-winterized marine source oil, optionally a food grade or pharmaceutically acceptable form of CoQ10 or a derivative thereof admixed in the non-winterized marine source oil, a food grade or pharmaceutically acceptable form of concentrated eicosapentaenoic acid and docosahexaenoic acid or ethyl ester, glyceride ester or salt of the acid and polyphenol rich vegetable oil admixed in the non-winterized marine source oil, and optionally a food grade or pharmaceutically acceptable form of melatonin or a derivative thereof admixed in the non-winterized marine source oil.
Type:
Grant
Filed:
June 12, 2017
Date of Patent:
July 28, 2020
Assignee:
AMBO INNOVATIONS, LLC
Inventors:
Bo Reidar Martinsen, Leif Andreas Riege
Abstract: Embodiments of the present invention are directed to methods, apparatus and articles of manufacture that feature omega-3 fatty acids co-processed with flavonoid and lipophilic antioxidants for improved stability.
Abstract: Embodiments of the present invention are directed to methods, apparatus and articles of manufacture that feature omega-3 fatty acids co-processed with flavonoid and lipophilic antioxidants for improved stability.
Abstract: The present invention relates to food products having a high omega-3 fatty acid content, as well as methods of preparing those food products.
Abstract: The present invention relates to food products having a high omega-3 fatty acid content, as well as methods of preparing those food products.
Abstract: A volume-adjustable device for the delivery of multiple medications to a subject, the device comprising multiple medication elements; an outer containment means having at least one open end into which the medication elements are removeably inserted; and a closure means removeably and adjustably inserted into at least one end of the outer containment means is disclosed.
Abstract: A medication delivery device by virtue of which multiple medications are produced in various medication delivery device forms, including particularly pill, capsule, gel-cap or soft gel form, which medication delivery device forms are readily identifiable by color or shape, and which medication delivery device forms are connected and affixed one to another, though the use of a bonding material, glue or adhesive, in a chain, train or string fashion, thus presenting to the patient that which appears to be only one item for ingestion or insertion into a live body, without the use or employment of any biodegradable outer container intended for ingestion or insertion into a live body, into which outer container the said various pills might have otherwise been inserted, and with said connection and affixation being intentionally separable to facilitate ingestion or to enable intentional selective removal of one or more connected or affixed components.